Geftinat Gefitinib 250 mg
Gefitinib 250 mg prescribed for non-small cell lung cancer with abnormal EGFR genes.
In stock
Description
The tablet is prescribed for treating non-small cell lung cancer in patients where the cancer has metastasized, who possess abnormal epidermal growth factor receptor (EGFR) genes, and have not undergone prior cancer treatment.
Additional information
| Drug Composition | Gefitinib 250 mg |
|---|---|
| Variant/Strength | 250 mg |
| Dosage Form/Type | Tablets |
| Product Benefits | Non-small cell lung cancer |
| Packaging | Bottle |
| Delivery Time | 7 – 15 Days, as per delivery location. |
| Country of Origin | Made in India |
Reviews
There are no reviews yet.